SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC. 20549
FORM 11-K
ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1993
Registration number 2-56218
A. Full title of the plan:
ORAL-B LABORATORIES SAVINGS PLAN
One Lagoon Drive
Redwood City, CA 94065
B. Name of the issuer of the securities held
pursuant to the plan and the address of its principal
executive office:
The Gillette Company
Prudential Tower Building
Boston, MA 02199
Financial Statements of the Oral-B Laboratories
Savings Plan
In lieu of the requirements of Items 1 through 3,
the Oral-B Laboratories Savings Plan is filing financial
statements and schedules prepared in accordance with
ERISA. Pursuant to Rule 311 of Regulation S-T, the
financial statements and schedules are being filed in
paper format under cover of Form SE and the following
legend will appear on the transmittal letter accompanying
the paper format documents:
THIS PAPER FORMAT DOCUMENT IS BEING
SUBMITTED IN ACCORDANCE WITH RULE 311 OF
REGULATION S-T.
Exhibits
24 Consent of KPMG Peat Marwick to the
incorporation by reference of the Plan's
financial statements into Registration
Statement No. 2-93230 on Form S-8 under
the Securities Act of 1933.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Savings Plan Committee has
duly caused this annual report to be signed on its behalf
by the undersigned hereunto duly authorized.
Oral-B Laboratories Savings Plan
By ROBERT E. DICENSO
Robert E. DiCenso
Senior Vice President-Administration
The Gillette Company
Date: June 27, 1994
Exhibit 24
CONSENT OF INDEPENDENT AUDITORS
The Savings Plan Committee
Oral-B Laboratories Savings Plan:
We consent to the incorporation by reference in the
registration statement
No. 2-93230 on Form S-8 of the Oral-B Laboratories
Savings Plan of our report dated April 21, 1994, relating
to the statements of net assets available for plan benefits
and schedule of assets held for investment purposes of
the Oral-B Laboratories Savings Plan as of December
31, 1993 and 1992, and the related statements of
changes in net assets available for plan benefits and
schedule of 5% reportable transactions for each of the
years in the three-year period ended December 31,
1993, which report appears in the December 31, 1994
annual report on Form 11-K of the Oral-B Laboratories
Savings Plan.
KPMGPEATMARWICK
KPMG Peat Marwick
Boston, Massachusetts
June 21, 1994
